Related Experiment Video

Updated: Aug 30, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.7K

Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired

Maxime Cahuzac1,2, Benjamin Péant1,2, Anne-Marie Mes-Masson1,2,3

  • 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC H2X 0A9, Canada.

Cancers
|August 26, 2022
PubMed
Abstract

Insights

Poly (ADP-ribose) polymerase inhibitors (PARPi) resistance in prostate cancer (PC) is not well understood. This study developed resistant cell lines, revealing altered DNA repair, cell cycle, and autophagy pathways, suggesting new targets to overcome PARPi resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Poly (ADP-ribose) polymerase inhibitors (PARPi) are used for breast and ovarian cancers with DNA damage mutations.
  • PARPi show promise in advanced prostate cancer (PC) but resistance eventually develops.
  • Understanding PARPi resistance mechanisms in PC is crucial for effective treatment strategies.

Purpose of the Study:

  • To develop in vitro models of PARPi resistance in prostate cancer.
  • To investigate the molecular pathways affected by acquired PARPi resistance.
  • To identify potential therapeutic targets for overcoming PARPi resistance in PC.

Main Methods:

  • Established olaparib-resistant (OR) prostate cancer (PC) cell lines from sensitive counterparts (LNCaP, C4-2B, DU145).
  • Performed microarray analysis to compare gene expression profiles between sensitive and OR cell lines.
  • Validated key gene expressions (BRCC3, ROCK2, ATG2B) and cellular processes (autophagy, homologous recombination).

Main Results:

  • Olaparib IC50 values significantly increased in OR cell lines.
  • Acquired resistance affected DNA repair, cell cycle regulation, and autophagy pathways.
  • ROCK2 expression, basal autophagy, and homologous recombination (HR) efficiency were elevated in all OR cell lines.

Conclusions:

  • Developed a novel in vitro model for studying PARPi resistance in PC.
  • Identified ROCK2, autophagy, and HR as potential targets to reverse PARPi resistance.
  • Findings suggest strategies to prolong the efficacy of PARPi treatment in prostate cancer.
Keywords:
DNA repairPARPautophagyprostate cancerresistance

More Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on: September 8, 2017

13.5K
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses08:36

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

11.2K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K